- Asbestos Exposure
- Consumer Fraud
- Human Rights
- Medical Devices
- Medical Drugs
- Nursing Home Abuse & Neglect
- Personal Injury & Wrongful Death
- Securities Class Actions
- Toxic Exposure
April 7, 2014
If you or someone you know took Actos or Duetact and developed bladder cancer, contact our medical team to learn if you may have a case.
Actos is manufactured by Takeda Pharmaceutical Company Limited and co-marketed in the United States by Eli Lilly and Company. It was originally approved by the FDA in 1999 to improve the control of blood sugar in adults with type 2 diabetes. The drug belongs to a class of drugs known as thiazolidinediones; medications intended to lower blood glucose levels and increase the body's sensitivity to insulin.
Some countries have taken a more aggressive approach to limiting the sale and prescription of Actos. Following the release of a French study showing a possible increased risk of bladder cancer with Actos use, both France and Germany suspended sales and prescriptions of the drug.
The FDA states it will continue to monitor data from the 10-year study, conduct a comprehensive review of the results from the French study and provide updates when more information becomes available.
When a drug you’re taking to improve one condition has unexpected harmful or even deadly side effects, it is your right to pursue justice and to seek to hold the manufacturer responsible. If you believe that you have a claim, contact us via email or call 1.800.768.4026.